Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | GENB | GPCR |
|---|---|---|
| Price | $13.91 | $27.59 |
| Change today | ▲ 1.61% | ▼ 0.29% |
| Market cap | $1.79B | $1.97B |
| Return, 3 months | -14.2% | -51.3% |
| Return, year to date | – | -60.3% |
| Return, 1 year | – | -3.8% |
| P/E (TTM) | -6.6 | -9.1 |
| P/B | 3.9 | 1.5 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | -72.2% |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | +86.9% | +283.6% |
| Analyst buy share | 100% | 100% |
| RSI (14) | 38 | 17 |
| 30-day volatility | 99.4% | 64.9% |
| Max drawdown, 1 year | -32.8% | -70.6% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
